Research & Studies

cpap live longer
Research & Studies

People on CPAP Live Longer, Research Shows

Using positive airway pressure therapy, as directed, can significantly increase sleep apnea patients’ chances of living longer, according to a late-breaking abstract presented today at the virtual European Respiratory Society (ERS) International Congress 2021 and supported by ResMed. The landmark ALASKA study, “CPAP Termination and All-Cause Mortality: a French Nationwide […]

sleep apnea and stroke
Home Sleep Testing (HST) Patient Health Research & Studies

STOP-BANG Plus HSAT Can Diagnose Sleep Apnea in Stroke Patients Before They Leave the Hospital

Sleep-disordered breathing is common in stroke patients. These patients don’t recover as quickly and are more likely to die or have a recurrent stroke, especially among non-white racial and ethnic populations. The American Heart Association/American Stroke Association guidelines recommend considering sleep studies in patients with acute stroke and transient ischemic […]

jazz sleep 2022
Research & Studies

Jazz Pharmaceuticals Presents 18 Abstracts at SLEEP 2021

Jazz Pharmaceuticals plc announced that 13 abstracts sponsored by Jazz Pharmaceuticals and five abstracts from investigator-sponsored trials will be presented at SLEEP 2021, the 35th annual meeting of the Associated Professional Sleep Societies (APSS) from June 10-13, 2021. “Jazz continues to be committed to deepening our understanding of sleep disorders and delivering […]

uva
Research & Studies

Antibiotics Don’t Help Deadly Lung-Scarring Disease

Doctors have hoped that antibiotics could benefit patients with chronic lung diseases, but a new study has found no benefit for patients with life-threatening idiopathic pulmonary fibrosis in preventing hospitalization or death. While there were no statistical benefits for patients with the lung-scarring disease, the new research will prevent unnecessary […]

Noctrix health restless legs syndrome
Research & Studies

Noctrix Health Enrolls First Patient in RLS Wearable Device Trial

Noctrix Health, Inc. announced that the first patient has been enrolled in a multi-center, randomized controlled clinical trial. The RESTFUL Study (ClinicalTrials.gov Identifier: NCT04874155) is a first of its kind two-phase, randomized, double-blind, sham-controlled clinical trial to evaluate the Company’s proprietary wearable NTX100 Neuromodulation System in patients with moderate-severe primary RLS […]